menu
    • menu

    Company profile for Agenus

    NEW Drugs in Dev: 21
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new t...
    Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new target discovery to GMP manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AgenusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3 Forbes Road Lexington, MA 02421-7305
    Telephone
    Telephone
    781.674.4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://agenusbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agenus
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/agenus?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Agenus To Unveil Systemic, Tumor Inflammation Biomarker Data
    Agenus To Unveil Systemic, Tumor Inflammation Biomarker Data

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209269639/en/Agenus-to-Present-New-Data-at-AACR-IO-Exploring-Systemic-and-Tumor-Inflammation-Biomarkers-with-BOTBAL-in-Immunologically-Cold-Tumors

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Agenus Expands Medical Affairs For Botensilimab & Blstilimab
    Agenus Expands Medical Affairs For Botensilimab & Blstilimab

    21 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260121295490/en/Agenus-Expands-Medical-Affairs-Infrastructure-to-Support-Increasing-Physician-Requests-for-Authorized-Access-to-Botensilimab-Plus-Balstilimab

    BUSINESSWIRE
    21 Jan 2026
    Share Share
    Agenus To Host First 2026 Stakeholder Webcast
    Agenus To Host First 2026 Stakeholder Webcast

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120995688/en/Agenus-to-Host-First-2026-Stakeholder-Webcast

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Zydus Lifesciences Completes the Acquisition of Agenus Facility
    Zydus Lifesciences Completes the Acquisition of Agenus Facility

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zydus-lifesciences-limited-completes-the-acquisition-of-agenus-incs-biologics-manufacturing-facilities-launches-zylidac-bio-llc-in-the-us-302662438.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    France Expands Agenus' Botensilimab + Balstilimab Access
    France Expands Agenus' Botensilimab + Balstilimab Access

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112699965/en/France-Expands-National-AAC-Access-for-Agenus-Botensilimab-Balstilimab-for-Ovarian-Cancer-and-Soft-Tissue-Sarcomas

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Agenus Reveals Strong Ovarian Cancer Responses With Botensilimab
    Agenus Reveals Strong Ovarian Cancer Responses With Botensilimab

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223989276/en/Agenus-Reports-Deep-Durable-Responses-with-Botensilimab-Balstilimab-in-Highly-Refractory-Ovarian-Cancer-Published-in-JITC

    BUSINESSWIRE
    23 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search